Xing-Hua Lu1, Li Wang, Hui Li, Jia-Ming Qian, Rui-Xue Deng, Lu Zhou. 1. Department of Gastroenterology, Peking Union Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, China. lxhbj2000@yahoo.com.cn
Abstract
AIM: To investigate risk factors for pancreatic cancer and establish a risk model for Han population. METHODS: This population-based case-control study was carried out from January 2002 to April 2004. One hundred and nineteen pancreatic cancer patients and 238 healthy people completed the questionnaire which was used for risk factor analysis. Logistic regression analysis was used to calculate odds ratio (ORs), 95% confidence intervals (Cls) and beta value, which were further used to establish the risk model. RESULTS: According to the study, people who have smoked more than 17 pack-years had a higher risk to develop pancreatic cancer compared to non-smokers or light smokers (not more than 17 pack-years) (OR 1.98; 95% CI 1.11-3.49, P = 0.017). More importantly, heavy smokers in men had increased risk for developing pancreatic cancer (OR 2.11; 95%CI 1.18-3.78, P = 0.012) than women. Heavy alcohol drinkers (>20 cup-years) had increased risk for pancreatic cancer (OR 3.68; 95%CI 1.60-8.44). Daily diet with high meat intake was also linked to pancreatic cancer. Moreover, 18.5% of the pancreatic cancer patients had diabetes mellitus compared to the control group of 5.8% (P = 0.0003). Typical symptoms of pancreatic cancer were anorexia, upper abdominal pain, bloating, jaundice and weight loss. Each risk factor was assigned a value to represent its importance associated with pancreatic cancer. Subsequently by adding all the points together, a risk scoring model was established with a value higher than 45 as being at risk to develop pancreatic cancer. CONCLUSION: Smoking, drinking, high meat diet and diabetes are major risk factors for pancreatic cancer. A risk model for pancreatic cancer in Chinese Han population has been established with an 88.9% sensitivity and a 97.6% specificity.
AIM: To investigate risk factors for pancreatic cancer and establish a risk model for Han population. METHODS: This population-based case-control study was carried out from January 2002 to April 2004. One hundred and nineteen pancreatic cancerpatients and 238 healthy people completed the questionnaire which was used for risk factor analysis. Logistic regression analysis was used to calculate odds ratio (ORs), 95% confidence intervals (Cls) and beta value, which were further used to establish the risk model. RESULTS: According to the study, people who have smoked more than 17 pack-years had a higher risk to develop pancreatic cancer compared to non-smokers or light smokers (not more than 17 pack-years) (OR 1.98; 95% CI 1.11-3.49, P = 0.017). More importantly, heavy smokers in men had increased risk for developing pancreatic cancer (OR 2.11; 95%CI 1.18-3.78, P = 0.012) than women. Heavy alcohol drinkers (>20 cup-years) had increased risk for pancreatic cancer (OR 3.68; 95%CI 1.60-8.44). Daily diet with high meat intake was also linked to pancreatic cancer. Moreover, 18.5% of the pancreatic cancerpatients had diabetes mellitus compared to the control group of 5.8% (P = 0.0003). Typical symptoms of pancreatic cancer were anorexia, upper abdominal pain, bloating, jaundice and weight loss. Each risk factor was assigned a value to represent its importance associated with pancreatic cancer. Subsequently by adding all the points together, a risk scoring model was established with a value higher than 45 as being at risk to develop pancreatic cancer. CONCLUSION: Smoking, drinking, high meat diet and diabetes are major risk factors for pancreatic cancer. A risk model for pancreatic cancer in Chinese Han population has been established with an 88.9% sensitivity and a 97.6% specificity.
Authors: G A Colditz; K A Atwood; K Emmons; R R Monson; W C Willett; D Trichopoulos; D J Hunter Journal: Cancer Causes Control Date: 2000-07 Impact factor: 2.506
Authors: D T Silverman; M Schiffman; J Everhart; A Goldstein; K D Lillemoe; G M Swanson; A G Schwartz; L M Brown; R S Greenberg; J B Schoenberg; L M Pottern; R N Hoover; J F Fraumeni Journal: Br J Cancer Date: 1999-08 Impact factor: 7.640
Authors: Nicholas P Webber; Sunil Sharma; Allie H Grossmann; Akram Shaaban; Kevin B Jones; Lester J Layfield; R Lor Randall Journal: J Clin Oncol Date: 2010-08-16 Impact factor: 44.544
Authors: Li Jiao; Debra T Silverman; Catherine Schairer; Anne C M Thiébaut; Albert R Hollenbeck; Michael F Leitzmann; Arthur Schatzkin; Rachael Z Stolzenberg-Solomon Journal: Am J Epidemiol Date: 2009-03-18 Impact factor: 4.897
Authors: Jeanine M Genkinger; Donna Spiegelman; Kristin E Anderson; Leif Bergkvist; Leslie Bernstein; Piet A van den Brandt; Dallas R English; Jo L Freudenheim; Charles S Fuchs; Graham G Giles; Edward Giovannucci; Susan E Hankinson; Pamela L Horn-Ross; Michael Leitzmann; Satu Männistö; James R Marshall; Marjorie L McCullough; Anthony B Miller; Douglas J Reding; Kim Robien; Thomas E Rohan; Arthur Schatzkin; Victoria L Stevens; Rachael Z Stolzenberg-Solomon; Bas A J Verhage; Alicja Wolk; Regina G Ziegler; Stephanie A Smith-Warner Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-03-03 Impact factor: 4.254
Authors: Seema Untawale; Andrew O Odegaard; Woon-Puay Koh; Ai Zhen Jin; Jian-Min Yuan; Kristin E Anderson Journal: PLoS One Date: 2014-01-15 Impact factor: 3.240
Authors: Anwar E Ahmed; Faris S Alzahrani; Ahmed M Gharawi; Salman A Alammary; Fahad H Almijmaj; Fahad M Alhusayni; Donna K McClish; Hamdan Al-Jahdali; Ashwaq A Al Olayan; Abdul Rahman Jazieh Journal: Cancer Manag Res Date: 2018-10-25 Impact factor: 3.989